To test whether TTI‐CD200 could have a functional effect on immune cells ex vivo, AML patient blasts with high or low levels of CD200 protein expression (as described in 6) were co‐cultured with their autologous lymphocytes in the presence of TTI‐CD200 or isotype control. Here, CD200 is linked to acute myeloid leukemia.